1. Alexandrova GI, Polezhaev FI, Budilovsky GN, Garrueshova LV. Recombinant cold-adapted attenuated influenza A vaccines for use in children. Reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccine. Infect Immun 1984; 44:734–740.
2. Maassab HF, DeBorde DC. Development and characterization of cold-adapted virus for use as live virus vaccines. Vaccine 1985; 3:355–369.
3. Maassab HF, Herlocher ML, Bryant ML. Live influenza virus vaccine. In: Orenstein WA, Plotkin SM, eds. Vaccines, 3rd ed. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: WB Saunders Co, Division of Harourt Brace and Co., 1998 (in press).
4. Enders JF, Shaffa ME Studies on natural immunity to pneumococcus type 14. Capacity of strains of pneumococcus type 111 to grow at 4ic and their virulence for rabbits. J Exp Med 1936; 7:64–70.
5. Burnet FM. The Use of Developing Egg in Virus Research. London, HM Stationary Office, Great Britain Medical Research Council, Special Report Series No 220, 1936.